Request Sample

Global HIV Diagnostics Market

March 17, 2018

Global HIV Diagnostics Market, By Product Type (Antibody Tests (HIV-1 Screening Tests {Home Access Dried Blood Spot, ELISA/EIA, Rapid Tests}, HIV-1 Confirmatory Tests {Indirect Immunofluorescent Antibody Assay (IFA), Western Blot Test, RadioImmuno-Precipitation (RIPA), Line Immunoassay (Cnf)}, HIV-2 & Group O Diagnostic Tests {DBS Tests, Blood Antibody Tests, Line Immunoassay (HIV2)}, Viral Identification Tests {Qualitative PCR Tests, p24 Antigen Test, Viral Culture}), Viral Load testing, CD4 Testing, and Early Infant Diagnostics), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Global Forecast, 2020-2025.

Report Code : FMR176      
Industry : Clinical Diagnostic
Pages : 215 Pages
Format :   PPT Format   PDF Format

The global HIV diagnostics market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020 and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). A considerable number of the world population infected with HIV and continuous efforts by medical researchers and experts for the development of improved HIV diagnostic tests are driving the global HIV diagnostics market over the forecast period.

Table 1. Global HIV Diagnostics Market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (Product Type)

Antibody Tests (HIV-1 Screening Tests {Home Access Dried Blood Spot, ELISA/EIA, Rapid Tests}, HIV-1 Confirmatory Tests {Indirect Immunofluorescent Antibody Assay (IFA), Western Blot Test, RadioImmuno-Precipitation (RIPA), Line Immunoassay (Cnf)}, HIV-2 & Group O Diagnostic Tests {DBS Tests, Blood Antibody Tests, Line Immunoassay (HIV2)}, Viral Identification Tests {Qualitative PCR Tests, p24 Antigen Test, Viral Culture}), Viral Load testing, CD4 Testing, and Early Infant Diagnostics

Regions Covered

North America, Latin America, Europe, Asia-Pacific, Middle East and Africa

Key Players Coverage

Abbott Healthcare, Alere Inc., Abbvie Inc., Janssen Therapeutics, Bristol-Myers Squibb, Merck & Co. Inc, Gilead Sciences, Sysmex, Apogee Flow Systems, BD Biosciences, VIIV Healthcare, Beckman Coulter, Zyomyx Inc., Mylan inc., PointCare Technologies Inc., Siemens Healthcare, and Roche Diagnostics among others

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

HIV is one of the major global public health issues and it is growing over the years. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS) 2019 data, in the world total, 37.9 million people were infected with HIV including 1.7 million children and 770,000 people died due to HIV-related illnesses. The government as well as health organizations are making efforts to create awareness and reduce HIV infection as well as death rates. These factors are creating critical needs for HIV medical facilities and demand for HIV diagnostics tests. 

Lack of a test to identify individuals carrying HIV was the major concern during the early phase of the HIV epidemic. Continuous research and evolution are going on for early HIV diagnosis and treatments. For instance, in June 2015, the FDA approved the fifth generation HIV test i.e., Bio-Rad BioPlex 2200 HIV Ag/Ab HIV antibody test, which provides results for HIV antibody and HIV-1 p24 antigen. Further, the detection of HIV infection in children and infants by implementing early infant test is reducing the high risk of deaths under the age of 2 years. These factors are providing a positive outlook for the HIV diagnostics market across the globe. Unavailability of various HIV diagnostic test in some developing countries such as the absence of Viral Load Testing in African countries may provide significant opportunities to the market players to tap into these regions and retain significant market share during the forecast period.

Figure 1. PORTER’S Analysis

 

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

The Middle East and Africa are expected to show significant CAGR in the HIV diagnostics market due to a rising prevalence of HIV/AIDS infections among the people. For instance, in 2017, as per the UNAIDS records, 19.6 million people in east & southern Africa, and 6.1 million people in western and central Africa were infected with HIV. These factors are creating more opportunities for industry players in the African region. The government of South Africa is running the world's largest HIV program and increasing their spending on reducing the rate of new HIV infections and HIV testing facilities, which is further boosting the market growth.

North America holds a substantial market share in the HIV diagnostics market owing to the availability of advanced medical facilities and HIV care services across the region. The rapid development of HIV diagnostics tests and the presence of major industry players are further fueling the HIV diagnostic market growth. For instance, in January 2018, Roche introduced the innovative cobas Plasma Separation Card for the collection of plasma for viral load testing. Plasma Separation Card can be used in any remote area, humidity, and extreme temperature.

Figure 2. Regional Analysis

 

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

Competitive Landscape

Key players in the global HIV diagnostics market include Abbott Healthcare, Alere Inc., Abbvie Inc., Janssen Therapeutics, Brsitol-Myers Squibb, Merck & Co. Inc, Gilead Sciences, Sysmex, Apogee Flow Systems, BD Biosciences, VIIV Healthcare, Beckman Coulter, Zyomyx Inc., Mylan inc., PointCare Technologies Inc., Siemens Healthcare, and Roche Diagnostics among others.

The industry players have adopted innovative growth strategies including product development, investment in R&D, and partnership to strengthen their position in the market. For instance, in July 2018, Abbott Healthcare launched an innovative solution- the viral load monitoring test m-PIMA HIV-1/2 VL. This innovative solution enabled the company to expand its product portfolio and reduce the risk for people living with HIV.

Figure 3. Market Share of Key Players, 2019

 

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

By Product Type

  • Antibody Tests
    • HIV-1 Screening Tests
      • Home Access Dried Blood Spot
      • ELISA/EIA
      • Rapid Tests
    • HIV-1 Confirmatory Tests
      • Indirect Immunofluorescent Antibody Assay (IFA)
      • Western Blot Test
      • RadioImmuno-Precipitation (RIPA)
      • Line Immunoassay (Cnf)
    • HIV-2 & Group O Diagnostic Tests
      • DBS Tests
      • Blood Antibody Tests
      • Line Immunoassay (HIV2)
    •  Viral Identification Tests
      • Qualitative PCR Tests
      • p24 Antigen Test
      • Viral Culture
  • Viral Load testing
  • CD4 Testing
  • Early Infant Diagnostics

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides an in-depth analysis of the global HIV diagnostics market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global HIV diagnostics market?
  • What key factors are expected to increase the demand for the HIV diagnostics market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global HIV diagnostics market?
  • What is the total market value (US$ Mn) generated in the global HIV diagnostics market by product type in 2019 and what are the forecasts by 2025?
  • What was the total revenue generated by the global HIV diagnostics market across different regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global HIV diagnostics market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the HIV diagnostics market?
  • What are the major outcomes derived from Porter’s five forces?
  • What new products are going to be approved or launched in the coming years which may have a huge impact on the global HIV diagnostics market?
  • What insights are derived through the analysis of key players on the following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?
Latest Reports

Global Sleep Testing Services Market

Global Sleep Testing Services Market, By Test Type (Home Sleep Testing and In-lab Sleep Testing (Electroencephalogram, Full Polysomnography, CPAP/BiPAP …

Read More

Global Sarcoma Biopsy Market

Global Sarcoma Biopsy Market, By Product Type (Reusable Device, Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic …

Read More

Global Rheumatoid Arthritis Diagnostic Tests Market

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (serology tests (erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic …

Read More

Global PARP Inhibitor Biomarkers Market

Global PARP Inhibitor Biomarkers Market, By Product and Service Type (Product Type, (Kits, Assays), Service Type, (BRCA 1 & …

Read More

North America Outbound Medical Tourism Services Market

North America Outbound Medical Tourism Services Market, By Treatment Type (Cardiovascular Treatment, Cosmetic Surgery Treatment, Dental Treatment, Weight Loss …

Read More

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product Type (Instruments and Reagents and Kits ), By …

Read More

Global Bilirubin Blood Test Market

Global Bilirubin Blood Test Market, By Test Type (Direct/Conjugated Bilirubin Test, Indirect/Unconjugated Bilirubin Test, Total Serum Bilirubin (TSB), By …

Read More

Global In Vitro Toxicity Testing Market

Global In Vitro Toxicity Testing Market, By Product & Service (Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based …

Read More
Validation error occured. Please enter the fields and submit it again.